U.S. Mortgage Finance Stock News

In August 2026, QIAGEN announced that the U.S. FDA had cleared its QIAstat-Dx BCID GPF Plus AMR Panel, the first QIAstat-Dx bloodstream infection panel to receive FDA clearance, expanding the platform’s U.S. coverage to four infectious disease areas and delivering one-hour pathogen and resistance marker results from positive blood cultures. This clearance not only broadens QIAGEN’s infectious disease testing menu on a single integrated platform, but also positions the company to address the...

Credit Acceptance (CACC) has drawn investor attention after completing a US$600 million asset backed non recourse secured financing and naming former Amazon executive Jeetu Mirchandani as Chief Technology Officer earlier this month. See our latest analysis for Credit Acceptance. These financing and leadership moves have come alongside a steady build in momentum for Credit Acceptance, with a 32.41% year to date share price return and a 1 year total shareholder return of 18.67% pointing to...

In the past quarter, Reliance reported strong Q2 2026 results, with adjusted earnings per share rising very large on the back of higher shipments, firmer pricing, and contributions from a U.S. border wall project, while management highlighted healthy demand across non-residential construction, aerospace, automotive, and semiconductor markets. An interesting angle is how the border wall project and improved gross profit per ton show Reliance monetising complex, project-based work alongside...

McGrath RentCorp (MGRC) is back in focus for investors after recent share price swings, with the stock last closing at $116.65. The move is prompting closer attention to its rental-focused business model. See our latest analysis for McGrath RentCorp. Recent trading in McGrath RentCorp has been choppy, with a 7 day share price return of down 4.6% and a 30 day share price return of down 2.6%. However, the year to date share price return of 10.85% and a 5 year total shareholder return of 82.79%...

Candel Therapeutics (CADL) is back in focus after reporting second quarter 2026 results that showed a net loss of US$38.91 million. This compared with net income for the first half of 2025. See our latest analysis for Candel Therapeutics. The earnings release has come alongside strong momentum in Candel Therapeutics' stock, with a 1 month share price return of 37.34% and a year to date share price return of 141.36%. The 3 year total shareholder return is very large at around 9x, suggesting...

Recent performance puts Eastman Chemical in focus Eastman Chemical (EMN) has moved onto investor watchlists after a recent share price run that left the stock up about 9% over the past month and roughly 15% year to date. See our latest analysis for Eastman Chemical. The recent 30 day share price return of 8.64% has helped Eastman Chemical regain some momentum after a flat 90 day move, even though the 5 year total shareholder return of 22.54% below zero shows a weaker longer term picture. If...

Earlier this week, Hyperliquid Strategies drew fresh attention after Donald Trump said CFTC Chair Mike Selig is working on a compliant legal route for the Hyperliquid exchange to operate in the U.S., spotlighting potential regulatory clarity for the platform. This shift toward a possible U.S.-compliant framework has sharpened the focus on how much of Hyperliquid Strategies’ appeal rests on regulatory momentum rather than established financial fundamentals. We’ll now examine how the prospect...

Brinker International (EAT) is in focus after reporting fourth quarter and full year results on August 12, 2026, along with higher fiscal 2027 revenue guidance and a larger share repurchase authorization. See our latest analysis for Brinker International. The stronger fourth quarter and full year earnings on August 12, the higher fiscal 2027 revenue guidance and the expanded buyback authorization have arrived alongside powerful momentum, with Brinker International’s 30 day share price return...

In August 2026, Teradyne, Inc. entered into a five-year senior secured revolving credit facility of US$1.00 billion with PNC Bank and other lenders, providing flexible funding for working capital and general corporate purposes without initially drawing on the line. A key feature of this agreement is that collateral, guarantees, and several restrictive covenants can be lifted if Teradyne maintains investment grade credit ratings from at least two major agencies, potentially giving the...

In August 2026, HighPeak Energy, Inc. reported past second-quarter results showing revenue of US$272.42 million and net income of US$82.28 million, with diluted earnings per share from continuing operations rising to US$0.59 compared with US$0.19 a year earlier. However, for the first half of 2026 the company recorded a net loss of US$45.17 million despite essentially flat year-on-year revenue, highlighting the contrast between a strong second quarter and weaker earlier performance. Next,...

Dole plc recently reported past second-quarter 2026 results, with sales of US$2,499.41 million and net income of US$25.98 million, while also recognizing relatively small impairment and asset write-down charges. Alongside these results, the Board reaffirmed its capital return approach by declaring a US$0.085 per-share cash dividend for the second quarter of 2026, matching the first-quarter payout and underscoring an ongoing cash distribution to shareholders. We will now examine how the...

In August 2026, Birkenstock Holding plc reported higher third-quarter sales year on year and raised its fiscal 2026 revenue growth guidance to 15%, targeting reported revenue at the upper end of EUR 2,300 million to EUR 2,350 million. Alongside this upgraded outlook, the company combined a US$1.00 billion follow-on equity offering with a planned US$500 million share repurchase, signaling a reshaping of its capital structure and balance between growth funding and share count reduction. We’ll...

Concentra Group Holdings Parent (CON) stock is in focus after the company announced that occupational medicine leader Jill Rosenthal will return as chief medical officer, succeeding longtime CMO Dr. John Anderson. See our latest analysis for Concentra Group Holdings Parent. Set against this leadership change, Concentra Group Holdings Parent’s recent momentum has been strong, with an 80.32% year to date share price return and a 49.48% total shareholder return over the past year, while shorter...

Why Middleby’s latest earnings are getting attention Middleby (MIDD) has drawn fresh attention after reporting second quarter and six month results that showed higher sales alongside sharply lower net income, paired with new guidance following the Food Processing spin off. The company reported second quarter sales of US$875.55 million compared with US$796.80 million a year earlier. Net income for the quarter was US$54.81 million compared with US$105.96 million in the prior year period. See...

In August 2026, NVIDIA Corporation announced memorandums of understanding with KKR & Co. Inc. and five other major financial institutions to create independent compute financing platforms, aiming to mobilize over US$500 billion of third-party capital for AI infrastructure across its ecosystem, subject to final agreements. This move positions KKR as an important capital partner in AI infrastructure financing, aligning its private markets expertise with rising demand for large-scale compute...

National Health Investors, Inc. reported second-quarter 2026 results showing year-on-year increases in sales to US$71.39 million, revenue to US$121.32 million, and net income to US$55.67 million, alongside higher earnings per share from continuing operations. Reinforcing these stronger earnings, the company’s board also approved a quarterly dividend increase to US$0.94 per share, signaling management’s confidence in cash flow durability and capital allocation priorities. We’ll now examine...

Permian Basin Royalty Trust recently declared a reduced cash distribution of US$0.018701 per unit for September 15, 2026, reflecting the absence of a prior settlement payment and weaker contributions from Texas Royalty Properties. Despite the lower payout, the trust’s latest quarterly report showed higher year-over-year revenue and net income, highlighting how commodity mix and one-off items can sharply influence monthly distributions. We’ll now examine how the reduced monthly...

Fresh interest in EOG Resources (EOG) has been driven by recent coverage highlighting its value metrics, earnings estimate revisions and history of strong returns. This has prompted many investors to reassess the stock’s current pricing. See our latest analysis for EOG Resources. Recent share price moves suggest momentum is building for EOG Resources, with a 7 day share price return of 7.32% and a year to date share price return of 42.68%. The 5 year total shareholder return of 178.34%...

UroGen Pharma (URGN) drew fresh investor attention after submitting a New Drug Application to the FDA for UGN-103, supported by Phase 3 UTOPIA trial data in recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. See our latest analysis for UroGen Pharma. The NDA news lands after a strong run for UroGen Pharma, with a 30-day share price return of 14.38%, a 90-day share price return of 62.20%, and a 1-year total shareholder return of 141.05% that signals building momentum...

Liquidia Corporation recently reported past second-quarter 2026 results showing revenue of US$171.68 million versus US$8.84 million a year earlier, with net income of US$74.72 million replacing a prior net loss and basic earnings per share from continuing operations rising to US$0.84. Over the first half of 2026, this shift from losses to profits and strong revenue expansion underscores how YUTREPIA’s commercialization and improved payer access are now translating more fully into the...

Deluxe (DLX) is back in focus after appointing Kevin Jones as President of its Merchant Services division, shortly after acquiring his company Celero Commerce. This acquisition helped position Deluxe as a top-10 non-bank merchant acquirer. See our latest analysis for Deluxe. Investors have seen Deluxe’s share price give back some ground recently, with a 1-month share price return that declined 9.26% and a 7-day share price return that declined 1.83%. However, the year-to-date share price...

Align Technology (ALGN) continues to draw investor attention after recent share price moves, with the stock last closing at $162.55. The company reported annual revenue of $4.14b and net income of $413.58m. See our latest analysis for Align Technology. Recent trading has been choppy for Align Technology, with a 1-day share price return of 2.27% following a 7-day share price decline of 10.35%, while the 1-year total shareholder return of 8.68% contrasts with a 3-year total shareholder return...

With US and Canada trade talks breaking down and fresh tariffs set to hit everything from steel to farm gear, investors are staring at a reshaped playing field where cross border supply chains may face higher costs and fresh uncertainty. That kind of disruption can punish some stocks yet open doors for others that lean on domestic production. This article walks through three stocks exposed to the latest tariff news and explains how they might fit into your watchlist. The stocks highlighted...

Microchip Technology has delivered a 17.0% gain year to date, yet the stock now screens as expensive, with both its Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples pointing to a premium price tag. For investors, that combination raises the question of how much of the company’s recent product progress in areas like space grade timing and edge AI connectivity is already reflected in the share price. The 17.0% year to date return can signal growing optimism around...